A $225 billion treatment market is badly in need of new therapies. Here is the roadmap for investors to capitalize on this opportunity.
Psychedelics
Mind Cure Announces Closing of Oversubscribed Upsized Initial Public Offering
Newest IPO hits September 21- MCUR
Functional Mushrooms: The Psychedelics Stepping Stone
Functional mushrooms are a large-and-growing health supplements market with synergies to psychedelics operations.
Champignon Provides Update on Disclosure Review
Champignon Brands continues to work with the BC Secutiries Commission to complete its disclosure review.
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
Mydecine is planning to spin out its U.S. legacy cannabis assets.
Compass Pathways Raising Up To $107.2 million For IPO, Valuation $500+ Million
Compass Pathways has set the terms for its IPO, targeting a valuation at or about $544.1 million.
Is Psilocybin More Revolutionary Than Spravato for Depression?
Spravato has not been the "game-changer" for treating depression that it was touted as being. The market remains wide open for psilocybin (and other psychedelics).
Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE
Havn Life Sciences commences trading on the CSE under the ticker symbol "HAVN".
ATAI Positioned As Kingmaker In Psychedelics Space
ATAI Life Sciences is looking more and more like the driving force in the psychedelic drug industry.
Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office
Aion Therapeutic Inc. has filed several plant-based patents with the USPTO.
Numinus Announces Filing Final Short Form Prospectus for Offering of up to $4,000,000
Numinus seeks to raise CAD$4.0 million at an offering price of CAD$0.25 per unit.
Havn Life Sciences Inc.: Havn Life Sciences Announces Filing of Final Prospectus and Conditional Approval for CSE Listing
Another private player in the psychedelics industry moves to go public. Prospectus available on SEDAR.
MagicMed Industries Closes Oversubscribed Private Placement of $1,642,880 with Mackie Research Capital Corporation
Calgary-based Magic Med Industries has raised CAD$1,642,880 from the sale of 6,571,520 shares.
Who is Mind Cure Health?
A new functional-and-psychedelic mushroom company is preparing to go public.